- Department of Neurosurgical, Helsinki University Central Hospital (HUCH), Helsinki, Finland
Correspondence Address:
Ali Harati
Department of Neurosurgical, Helsinki University Central Hospital (HUCH), Helsinki, Finland
DOI:10.4103/2152-7806.92170
Copyright: © 2012 Harati A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.How to cite this article: Harati A, Jarno Satopää, Mahler L, Billon-Grand R, Elsharkawy A, Mika Niemelä, Hernesniemi J. Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von Hippel–Lindau disease. Surg Neurol Int 21-Jan-2012;3:6
How to cite this URL: Harati A, Jarno Satopää, Mahler L, Billon-Grand R, Elsharkawy A, Mika Niemelä, Hernesniemi J. Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von Hippel–Lindau disease. Surg Neurol Int 21-Jan-2012;3:6. Available from: http://sni.wpengine.com/surgicalint_articles/early-microsurgical-treatment-for-spinal-hemangioblastomas-improves-outcome-in-patients-with-von-hippel-lindau-disease/
Abstract
Background:Spinal hemangioblastomas (HB) are rare, histologically benign, highly vascularized tumors often associated with von Hippel–Lindau (VHL) disease. The aim of the current study is to demonstrate the benefit of early surgical resection of large spinal HBs in selected asymptomatic patients with VHL.
Methods:Seventeen patients underwent microsurgical resection of 20 spinal HBs at the Department of Neurosurgery at Helsinki University Central Hospital (HUCH). Thirteen tumors were in the cervical spine, five in thoracic and one patient had two lumbar lesions. MRI tumor showed an associated syrinx in 16 patients (94%). Tumor volume ranged from 27 to 2730 mm3. Out of 17 patients, 11 (65%) tested positive for VHL in mutation analysis. Five of these patients with tumors ranging from 55 to 720 mm3 were treated prophylactically.
Results:Complete tumor resection was performed in 16 patients (94%) who were followed up for a median of 57 months (range 2–165 months). No patient had neurological decline on long-term follow-up. Among the patients with VHL, five patients with preoperative sensorimotor deficits showed improvement of their symptoms but never regained full function. One patient who presented with tetraplegia remained the same. Otherwise, all five patients with prophylactic surgery remained neurologically intact.
Conclusion:Although documented growth on serial MRIs and the need for pathological diagnosis have been suggested as indications for surgery in otherwise asymptomatic patients, our series showed that a potentially larger group of asymptomatic patients with spinal HB associated with VHL would benefit from microsurgical resection. Long-term results of the surgical management of spinal HB are generally favorable. Our results suggest staging and early treatment for spinal HB larger than 55 mm3, especially in patients with VHL. Small spinal HBs may be followed up.
Keywords: Spinal cord, spinal hemangioblastoma, McCormick classification, microsurgery, von Hippel–Lindau
INTRODUCTION
Hemangioblastomas (HBs) are rare, histologically benign, highly vascularized tumors of the central nervous system that can be cured with current microsurgical techniques. Although representing only 2–11% of all spinal cord tumors, 45% of spinal HBs occur with von Hippel-Lindau (VHL) disease. Neurological sequelae of spinal HBs often relate to the development of edema or syrinx.[
The neurological outcome of patients with spinal HB, undergoing microsurgical resection, relates both to preoperative clinical condition and to tumor anatomy. The preoperative functional status, as scored by the McCormick classification, typically correlates with postoperative neurological outcome [
Table 1
McCormick classification for intramedullary spinal cord tumors[
Although documented growth on serial MRIs and the need for pathological diagnosis have been indications for surgery in otherwise asymptomatic patients, it has been suggested that a potentially larger group of asymptomatic patients with spinal HB who would benefit from resection.[
MATERIALS AND METHODS
Patients and hemangioblastomas
Between January 1997 and March 2011, 164 patients with HBs of the central nervous system were treated in our department. Ten men and seven women had altogether 20 spinal HBs resected during this period. Patient files and images were reviewed in a retrospective study [
Imaging
In all patients, pre- and postoperative spinal axis MRI was performed using standard T1- and T2-weighted sequences. All MR images of the head and spine were evaluated separately by two authors (AH and JS). The anatomical site of the lesion in neural axis and the presence of syrinx were recorded. The volume of the tumor was assessed in three planes using the xyz × 0.5 method: [volume = length (x) × width (y) × height (z) × 0.5].[
Surgical techniques
Indications for tumor resection were progressive neurological deterioration or large size. Preoperative embolization was used in only one patient. Intraoperative fluoroscopy was routinely used for planning the incision. A midline incision and a routine subperiosteal dissection of the soft tissues were performed. Either a hemilaminectomy or a laminectomy with preservation of the facet joints was performed. It was not necessary to expose the spinal cord over the rostral and caudal cysts of the solid tumor. After hemilaminectomy, the tumor was approached by sharp incision of the dura and arachnoid and exposure of the affected spinal cord segment. The entire surgical dissection was done under high magnification of the operating microscope (×12). On inspection, the spinal cord usually appeared rotated and distorted, and careful inspection was necessary to identify the normal landmarks before placement of the myelotomy. Myelotomy was performed at the discolored or bulging medullary surface. Since 2007, indocyanine-green (ICG) videoangiography has routinely been used in our department to identify the tumor and feeding vessels. The interface between the pia and the tumor was identified and then circumferentially detached. In order to control intraoperative hemorrhage, temporary artery occlusion was performed with small aneurysm clips in eight patients. During sharp dissection, surface draining veins were isolated and closed. The dura was closed in a watertight manner to prevent cerebrospinal fluid leak.
Illustrative case reports
Patient 3#
A previously healthy, 16-year-old man with recently diagnosed maternally inherited VHL was referred to our Neurosurgical Department for tumor exclusion. His mother (patient 1#) had been operated for a cervical HB 1 year before. Neurological examination demonstrated diminished visual acuity in the right eye. Thoracocervical MRI showed a 408 mm3 HB at the Th2-3 level [
Patient 13#
A previously healthy, 32-year-old man with a known family history of VHL developed back pain, gait instability, spastic tetraparesis, ataxia, and diminished fine motor functions of both upper and lower extremities (McCormick grade 4). Because of indolence, he presented 6 months after the initial symptoms developed. A contrast-enhanced MR scan of the brain and spinal column and spinal DSA demonstrated a bilobed HB in the cervical spinal cord at the C2-3 level (sized 2700 mm3) and several small HBs in the cerebellum [Figures
RESULTS
Patients’ characteristics
The mean age of the 17 patients was 43 years (range 16-78 years). The mean age was 34 years for the VHL patients and 56 years for non-VHL patients. Multiple lesions occurred in four patients. Overall, 11 patients (65%) tested positive for VHL in mutation analysis. Thirteen lesions were located in the cervical spine, five in thoracic, and one patient had two lumbar lesions. MRI demonstrated an adjoining syrinx to be present in 16 patients (94%). Tumor volume ranged from 27 to 2730 mm3. A tumor volume above 600 mm3 was always associated with neurological deficits. Notably, two patients with tumor volume below 55 mm3 did demonstrate symptoms. Three patients had isolated sensory deficits and back pain as the presenting symptom. Mild progressive sensorimotor deficits were present in five patients, whilst one patient developed sudden paraplegia and one developed tetraplegia without hemorrhage. One patient (illustrative case 2) developed tetraparesis, which progressed into tetraplegia because of indolence. Three patients presenting with tumor regrowth had prior operative treatment at other hospitals. Prophylactic surgery was performed in five patients with VHL.
Operative procedure and postoperative course
Ten patients (59%) underwent hemilaminectomy and seven (41%) underwent laminectomy. Intraoperative ICG was used in five patients to help in identifying the tumor and the feeding vessels. Complete tumor resection was possible in 16 (94%) patients. Due to poor clinical condition, only a biopsy together with decompression of the lumbar spine was performed in one patient (patient #4). He developed postoperative wound infection requiring open revision. However, he recovered from grade 3 to 2. There were two other patients requiring revision surgery. Patient #1 was operated twice since the tumor could not be detected in the first operation; in a second operation with application of ICG, complete tumor removal was achieved. One patient who was embolized and operated on developed progressive tetraparesis, but improved in the long term. There was only one case (6%) of postoperative hematoma and spinal instability requiring fusion in the same patient.
Radiological and clinical long-term follow-up
Patients were followed up for a median of 57 months (range 2-165 months) [
Table 4
Long-term results according to Mc Cormick grade[
DISCUSSION
The present series together with an extensive review of literature showed the importance of staging and early surgery for spinal HBs in patients with VHL. Five asymptomatic VHL patients with tumor volumes from 55 to 720 mm3 did not develop any postoperative neurological sequelae after microsurgical resection and had no residual in long-term follow-up. Otherwise, none of the five VHL patients who presented with neurological deficit fully recovered to McCormick grade 1 despite postoperative improvement during long-term follow-up. The decision to operate on a patient with a spinal HB has historically been reserved for symptomatic patients with progressive deficits, and growth on serial MRIs and histological diagnosis in asymptomatic patients with sporadic occurrence.[
Clinical considerations
Symptoms usually range from mild sensory or motor deficits to complete para- or tetraplegia. Occasionally, bulbar symptoms from high cervical tumors or cervicomedullary syrinxes may occur. In concordance with the published literature, sensory dysfunction was the most prevalent initial symptom in our series.[
Radiographic considerations
Contrast-enhanced MRI is the diagnostic modality of choice for spinal HBs. Most authors have supported the use of angiography to visualize the relevant vasculature preoperatively.[
Operative techniques
Since the late 1980s, there have been 15 clinical series with more than 10 cases of spinal HB reported in the literature [
Long-term outcome
The long-term surgical outcome of patients with HB depends on preoperative neurological function. Long-term survival also depends on the progress of other lesions, especially in patients with VHL.[
CONCLUSION
Long-term results of the surgical management of spinal HB are generally favorable. Improvements in microsurgical techniques, including the addition of intraoperative ICG and temporary arterial occlusion, make complete tumor removal without neurological deterioration feasible. The systematic removal of asymptomatic lesions in the 50-mm3 size range should be considered to improve patient's prognosis in the future.
ACKNOWLEDGEMENT
We want to thank the Ehrnooth foundation for financial support of Dr. Harati and Dr. Elsharkawy for their fellowship at the Neurosurgical department of the Helsinki University Central Hospital.
Additionally, we want to thank Dr. Ecker for scientific advice and language editing.
References
1. Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: Implications for treatment. J Neurosurg. 2006. 105: 248-55
2. Boström A, Hans F, Reinacher PC, Krings T, Bürgel U, Gilsbach JM. Intramedullary hemangioblastomas: Timing of surgery, microsurgical technique and follow-up in 23 patients. Eur Spine J. 2008. 17: 882-6
3. Chu BC, Terae S, Hida K, Furukawa M, Abe S, Miyasaka K. MR findings in spinal hemangioblastoma: Correlation with symptoms and with angiographic and surgical findings. AJNR Am J Neuroradiol. 2001. 22: 206-17
4. Clark AJ, Lu DC, Richardson RM, Tihan T, Parsa AT, Chou D. Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg. 2010. 74: 200-5
5. Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001. 48: 55-62
6. Cornelius JF, Saint-Maurice JP, Bresson D, George B, Houdart E. Hemorrhage after particle embolization of hemangioblastomas: Comparison of outcomes in spinal and cerebellar lesions. J Neurosurg. 2007. 106: 994-8
7. Cristante L, Herrmann HD. Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir (Wien). 1999. 141: 333-9
8. Da Costa LB, de Andrade A, Braga BP, Ribeiro CA. Cauda equina hemangioblastoma: Case report. Arq Neuropsiquiatr. 2003. 61: 456-8
9. Glasker S, Van Velthoven V. Risk of hemorrhage in hemangioblastomas of the central nervous system. Neurosurgery. 2005. 57: 71-6
10. Hwang SW, Malek AM, Schapiro R, Wu JK. Intraoperative use of indocyanine green fluorescence videography for resection of a spinal cord hemangioblastoma. Neurosurgery. 2010. 67: ons300-
11. Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003. 98: 106-16
12. Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM. von Hippel-Lindau disease. Lancet. 2003. 361: 2059-67
13. Lonser RR, Vortmeyer AO, Butman JA, Glasker S, Finn MA, Ammerman JM. Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol. 2005. 58: 392-9
14. Lunardi P, Cervoni L, Maleci A, Fortuna A. Isolated haemangioblastoma of spinal cord: Report of 18 cases and a review of the literature. Acta Neurochir (Wien). 1993. 122: 236-9
15. Malis LI. Atraumatic bloodless removal of intramedullary hemangioblastomas of the spinal cord. J Neurosurg. 2002. 97: 1-6
16. Mandigo CE, Ogden AT, Angevine PD, McCormick PC. Operative management of spinal hemangioblastoma. Neurosurgery. 2009. 65: 1166-77
17. McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990. 72: 523-32
18. Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR. Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine. 2010. 12: 233-42
19. Montano N, Doglietto F, Pedicelli A, Albanese A, Lauretti L, Pallini R. Embolization of hemangioblastomas. J Neurosurg. 2008. 108: 1063-4
20. Moss JM, Choi CY, Adler JR, Soltys SG, Gibbs IC, Chang SD. Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas. Neurosurgery. 2009. 65: 79-85
21. Murakami T, Koyanagi I, Kaneko T, Iihoshi S, Houkin K. Intraoperative indocyanine green videoangiography for spinal vascular lesions: Case report. Neurosurgery. 2011. 68: 241-5
22. Murota T, Symon L. Surgical management of hemangioblastoma of the spinal cord: A report of 18 cases. Neurosurgery. 1989. 25: 699-707
23. Niemelä M, Lemeta S, Summanen P, Böhling T, Sainio M, Kere J. Long-term prognosis of haemangioblastoma of the CNS: Impact of von Hippel-Lindau disease. Acta Neurochir (Wien). 1999. 141: 1147-56
24. Oppenlander ME, Spetzler RF. Advances in spinal hemangioblastoma surgery. World Neurosurg. 2010. 74: 116-7
25. Parker F, Aghakhani N, Ducati LG, Yacubian-Fernandes A, Silva MV, David P. Results of microsurgical treatment of medulla oblongata and spinal cord hemangioblastomas: A comparison of two distinct clinical patient groups. J Neurooncol. 2009. 93: 133-7
26. Pietilä TA, Stendel R, Schilling A, Krznaric I, Brock M. Surgical treatment of spinal hemangioblastomas. Acta Neurochir (Wien). 2000. 142: 879-86
27. Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI. Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery. 2001. 49: 321-7
28. Samii M, Klekamp J. Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery. 1994. 35: 865-73
29. Sciubba DM, Mavinkurve GG, Gailloud P, Garonzik IM, Recinos PF, McGirt MJ. Preoperative imaging of cervical spine hemangioblastomas using three-dimensional fusion digital subtraction angiography. Report of two cases. J Neurosurg Spine. 2006. 5: 96-100
30. Shin DA, Kim SH, Kim KN, Shin HC, Yoon DH. Surgical management of spinal cord haemangioblastoma. Acta Neurochir (Wien). 2008. 150: 215-20
31. Takai K, Taniguchi M, Takahashi H, Usui M, Saito N. Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome. Neurol Med Chir (Tokyo). 2010. 50: 560-7
32. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003. 98: 82-94
33. Wu T, Guo W, Lirng J, Wong T, Chang F, Luo C. Spinal cord hemangioblastoma with extensive syringomyelia. J Chin Med Assoc. 2005. 68: 40-4
34. Xu QW, Bao WM, Mao RL, Yang GY. Magnetic resonance imaging and microsurgical treatment of intramedullary hemangioblastoma of the spinal cord. Neurosurgery. 1994. 35: 671-5
35. Yang Y, Wang D, Jiang H, Sha C, Yuan Q, Liu J. [Treatment of spinal cord hemangioblastoma by microoperations combined with embolization]. Zhonghua Yi Xue Za Zhi. 2008. 88: 1309-12